Skip to main navigation
Skip to search
Skip to main content
Ben-Gurion University Research Portal Home
Help & FAQ
Home
Profiles
Research output
Research units
Prizes
Press/Media
Student theses
Activities
Research Labs / Equipment
Datasets
Projects
Search by expertise, name or affiliation
Adjuvant therapy of large bowel carcinoma
G. Ezekiel, S. Walfisch, Y. Cohen
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adjuvant therapy of large bowel carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adjuvant Therapy
100%
Large Intestine
100%
Carcinoma
100%
5-fluorouracil (5-FU)
100%
5-year Survival
75%
Positive Lymph Nodes
75%
Levamisole
75%
National Institutes of Health
50%
Left Colon
50%
No Significant Difference
25%
Colon Cancer
25%
Progressive Disease
25%
Colon
25%
Intravenous Dose
25%
Diarrhea
25%
Consensus Conference
25%
Cancer Location
25%
Neutropenic Fever
25%
Adjuvant Chemotherapy
25%
Right versus Left
25%
Relapse-free Survival
25%
Leucovorin
25%
Right Colon
25%
Stomatitis
25%
Health Guidelines
25%
Actuarial Survival
25%
Bone Marrow Suppression
25%
Medicine and Dentistry
Adjuvant Therapy
100%
Colon
100%
Large Intestine Carcinoma
100%
Lymph Node
75%
Levamisole
75%
Side Effect
50%
Malignant Neoplasm
25%
Intravenous Drug Administration
25%
Progressive Disease
25%
Population Research
25%
Colon Cancer
25%
Diarrhea
25%
Recurrence Free Survival
25%
Adjuvant Chemotherapy
25%
Stomatitis
25%
Folinic Acid
25%
Bone Marrow Suppression
25%
Febrile Neutropenia
25%
Pharmacology, Toxicology and Pharmaceutical Science
Large Intestine Carcinoma
100%
Levamisole
100%
Side Effect
66%
Disease
33%
Malignant Neoplasm
33%
Colon Cancer
33%
Chemotherapy
33%
Population Study
33%
Diarrhea
33%
Recurrence Free Survival
33%
Stomatitis
33%
Bone Marrow Suppression
33%
Folinic Acid
33%
Febrile Neutropenia
33%